drugset / Trial / NCT00507806

Microbubble-Enhanced Clotbust Treatment of Acute Ischemic Stroke

NCT00507806

Phase 1/2 Terminated ImaRx Therapeutics
RandomizedParallel-groupOpen-labelTreatment

Summary

The study is designed to examine the safety, tolerability, and activity of a combination of microbubbles (perflutren lipid microsphere \[Definity®\]) and continuous monitoring with 2 MHz transcranial Doppler ultrasound (TCD) as an adjunctive therapy to tissue plasminogen activator (tPA) treatment in subjects with acute ischemic stroke.

Timeline

Start
2005-03
Primary completion
Completion
2006-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Definity Diagnostic / imaging agent

Indications